Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 May;83(5):1466-71.
doi: 10.1172/JCI114039.

Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes

Affiliations

Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes

J A Halperin et al. J Clin Invest. 1989 May.

Abstract

The lytic effect of complement on human erythrocytes has been reported by others to increase when Na+ is substituted for K+ in the external medium. In this paper we have investigated the hypothesis that net loss of K+ through a K+ transport pathway protects erythrocytes from complement-induced colloidosmotic swelling and lysis. Antibody-sensitized human erythrocytes containing different intracellular cation concentrations (nystatin treatment) were exposed to low concentrations of guinea pig serum in media of different cation composition; complement lysis was assessed by the release of hemoglobin and the volume of the surviving cells estimated by their density distribution profiles. Complement-dependent swelling and lysis of erythrocytes (a) were limited by the presence of an outwardly directed K+ electrochemical gradient and (b) were enhanced by carbocyanine, a specific inhibitor of the Ca2+-activated K+ transport pathway, and by absence of Ca2+ in the external medium. We propose that during complement activation a rising cytosolic calcium triggers the Ca2+-activated K+ permeability pathway, the Gardos effect, produces a net K+, Cl- and water loss, and thus limits the colloidosmotic swelling and lysis of erythrocytes.

PubMed Disclaimer

References

    1. Complement Inflamm. 1989;6(1):65-72 - PubMed
    1. J Clin Invest. 1988 Aug;82(2):594-600 - PubMed
    1. Immunology. 1969 Oct;17(4):559-69 - PubMed
    1. J Immunol. 1973 Aug;111(2):527-35 - PubMed
    1. J Immunol. 1975 Jul;115(1):63-8 - PubMed

Publication types